top of page


Between invention and impact: what INPI and GII data reveal about the urgency of health innovation in Brazil
In recent years, Brazil has faced a persistent paradox: it produces ever-increasing amounts of science, but continues to transform little...
Oct 86 min read


Global Pharmaceutical Innovation to 2029: Trends, Challenges and Brazil's Place
The global pharmaceutical and biotechnology industry is experiencing a period of accelerated growth in drug use and spending, driven by...
Jul 1630 min read


Building Global Power: A National Strategy for Deeptech Health Startups in Brazil
The emergence of cutting-edge technologies, known as deeptechs, marks a new phase in global innovation. These technologies, which emerge...
Jun 633 min read


The Construction of Innovation Ecosystems as a National Strategy: The Case of Health
In the contemporary global landscape, the concept of an isolated national economy has become a fiction. Nations do not compete solely for...
Feb 206 min read


The Importance of Regulatory Agencies in Health Innovation and Pharmaceutical Regulation: FDA, EMA, and ANVISA in Perspective
Health innovation and the remarkable growth of the pharmaceutical sector—with a projected global revenue of USD 1.155 trillion in...
Nov 1, 20244 min read
bottom of page
